BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28878175)

  • 1. Modelled Cost-Effectiveness of a Package Size Cap and a Kilojoule Reduction Intervention to Reduce Energy Intake from Sugar-Sweetened Beverages in Australia.
    Crino M; Herrera AMM; Ananthapavan J; Wu JHY; Neal B; Lee YY; Zheng M; Lal A; Sacks G
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Modelled Population Obesity-Related Health Benefits of Reducing Consumption of Discretionary Foods in Australia.
    Lal A; Peeters A; Brown V; Nguyen P; Tran HNQ; Nguyen T; Tonmukayakul U; Sacks G; Calache H; Martin J; Moodie M; Ananthapavan J
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US.
    Du M; Griecci CF; Cudhea FF; Eom H; Kim DD; Wilde P; Wong JB; Wang YC; Michaud DS; Mozaffarian D; Zhang F;
    JAMA Netw Open; 2021 Apr; 4(4):e217501. PubMed ID: 33904914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the Price of Alcohol as an Obesity Prevention Measure: The Potential Cost-Effectiveness of Introducing a Uniform Volumetric Tax and a Minimum Floor Price on Alcohol in Australia.
    Robinson E; Nguyen P; Jiang H; Livingston M; Ananthapavan J; Lal A; Sacks G
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeled health economic and equity impact on dental caries and health outcomes from a 20% sugar sweetened beverages tax in Australia.
    Nguyen TM; Tonmukayakul U; Khanh-Dao Le L; Singh A; Lal A; Ananthapavan J; Calache H; Mihalopoulos C
    Health Econ; 2023 Nov; 32(11):2568-2582. PubMed ID: 37477540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study.
    Wanjau MN; Kivuti-Bitok LW; Aminde LN; Veerman JL
    Cost Eff Resour Alloc; 2023 Sep; 21(1):69. PubMed ID: 37735408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study.
    Ananthapavan J; Sacks G; Brown V; Moodie M; Nguyen P; Veerman L; Mantilla Herrera AM; Lal A; Peeters A; Carter R
    PLoS One; 2020; 15(6):e0234804. PubMed ID: 32559212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of obesity attributable to the consumption of sugar-sweetened beverages in Brazil.
    da Silva BF; de Arruda Neta ADCP; de Alencar Rodrigues RE; de Araújo JM; Moreira PVL; Ferreira FELL; de Toledo Vianna RP; da Silva Neto JM; de Carli E; de Lima RLFC
    Sci Rep; 2024 Jun; 14(1):13936. PubMed ID: 38886385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of reducing children's sedentary time and increasing physical activity at school: the Transform-Us! intervention.
    Brown V; Sheppard L; Salmon J; Arundell L; Cerin E; Ridgers ND; Hesketh KD; Daly RM; Dunstan DW; Brown H; Gatta JD; Chinapaw JMM; Moodie M
    Int J Behav Nutr Phys Act; 2024 Feb; 21(1):15. PubMed ID: 38347579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis.
    Fuller NR; Carter H; Schofield D; Hauner H; Jebb SA; Colagiuri S; Caterson ID
    Int J Obes (Lond); 2014 Aug; 38(8):1104-9. PubMed ID: 24301133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-related health impacts of fuel excise taxation- an evidence review and cost-effectiveness study.
    Brown V; Moodie M; Cobiac L; Mantilla Herrera AM; Carter R
    BMC Public Health; 2017 May; 17(1):359. PubMed ID: 28468618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of sedentary behaviour interventions in offices to reduce sitting time in Australian desk-based workers: A modelling study.
    Nguyen P; Ananthapavan J; Gao L; Dunstan DW; Moodie M
    PLoS One; 2023; 18(6):e0287710. PubMed ID: 37384626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health, cost and equity impacts of restrictions on the advertisement of high fat, salt and sugar products across the transport for London network: a health economic modelling study.
    Thomas C; Breeze P; Cummins S; Cornelsen L; Yau A; Brennan A
    Int J Behav Nutr Phys Act; 2022 Jul; 19(1):93. PubMed ID: 35897072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK's sugar tax hits the sweet spot.
    Jones A; Wu JHY; Buse K
    BMJ; 2021 Mar; 372():n463. PubMed ID: 33704082
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of pharmacotherapy to reduce obesity.
    Veerman JL; Barendregt JJ; Forster M; Vos T
    PLoS One; 2011; 6(10):e26051. PubMed ID: 22046255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Obesity in Norway (The MOON Study): A Decision-Analytic Approach-Prevalence, Costs, and Years of Life Lost.
    Bjørnelv GMW; Halsteinli V; Kulseng BE; Sonntag D; Ødegaard RA
    Med Decis Making; 2021 Jan; 41(1):21-36. PubMed ID: 33256539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public Health and Legal Arguments in Favor of a Policy to Cap the Portion Sizes of Sugar-Sweetened Beverages.
    Roberto CA; Pomeranz JL
    Am J Public Health; 2015 Nov; 105(11):2183-90. PubMed ID: 26378833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia.
    Law CK; Cust AE; Smit AK; Trevena L; Fernandez-Penas P; Nieweg OE; Menzies AM; Wordsworth S; Morton RL;
    Genet Med; 2023 Dec; 25(12):100970. PubMed ID: 37658729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The return on investment for the prevention and treatment of childhood and adolescent overweight and obesity in China: a modelling study.
    Ma G; Meyer CL; Jackson-Morris A; Chang S; Narayan A; Zhang M; Wu D; Wang Y; Yang Z; Wang H; Zhao L; Nugent R
    Lancet Reg Health West Pac; 2024 Feb; 43():100977. PubMed ID: 38456086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.